Oncoinvent (OSLO: ONCIN)

Last close As at 18/11/2026

NOK71.20

▲ 0.20 (0.28%)

Market capitalisation

NOK437m

Oncoinvent is a biotechnology company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose.

Share Price Chart

Market Data

Share Price NOK71.20
Market Cap NOK437m
52-Week High NOK144.00
52-Week Low NOK40.10
% Change 1M 5.6
% Change 6M 49.9
% Change 12M 41.8
Ave. Daily Volume 1yr 13,026

Sector

Healthcare

Equity Analyst

Key Management

  • Øystein Soug

    CEO

  • Ramzi Amri

    CFO

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.